To advance our understanding of the role of nanotechnology in improving drug formulation properties, improving drug efficacy and reducing adverse side effects.
Nanotechnology has the potential to improve the formulation characteristics of drugs, improve targeting of drugs to target diseases and reduce the adverse side effects of drugs by shifting the distribution of drugs to the target disease. Nanotechnology also has the potential to be utilized for improved imaging of drug distribution and disease treatment. There is a growing need to better understand the characterization and tools needed to assess nanotechnology based products by the FDA. This focus group was assembled from a cohort of NIPTE faculty members that have expertise on the development, characterization and testing of nanoparticle based medicines.